Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-015533-79Phase 4Terminated
Phase 4, randomised trial of metahydroxylamine, epinephrine, dobutamine, dopexamine and norepinephrine in None (5 arms), sponsored by Oxford University Hospitals. Primary endpoint: Absolute change in flap vascular resistance. Started Jun 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-015533-79.